Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC)

Conditions

• Post COVID-19 Condition
• Long COVID Syndrome
• Persistent COVID-19
• Persistent COVID Condition
• Long COVID

Interventions

• DRUG: Plitidepsin 1.5 mg/day
• DRUG: Placebo
• DRUG: Placebo and Plitidepsin 1.5mg/day

Sponsor

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Collaborators

• [object Object]
• [object Object]